A new perspective on deoxynivalenol and growth suppression.
Voss
Kenneth A
KA
Toxicology and Mycotoxin Research Unit, United States Department of Agriculture, Agricultural Research Service, Athens, Georgia 30604-5677, USA. ken.voss@ars.usda.gov
D002352:Carrier Proteins / Q000187:drug effects / Q000378:metabolism; D016207:Cytokines / Q000187:drug effects / Q000378:metabolism; D006023:Glycoproteins / Q000187:drug effects / Q000378:metabolism; D013006:Growth Hormone / Q000187:drug effects / Q000378:metabolism; D006131:Growth Inhibitors / Q000633:toxicity*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000187:drug effects / Q000378:metabolism; D050826:Suppressor of Cytokine Signaling Proteins / Q000187:drug effects / Q000378:metabolism; D014255:Trichothecenes / Q000633:toxicity*
D002352:Carrier Proteins; D016207:Cytokines; D006023:Glycoproteins; D006131:Growth Inhibitors; D050826:Suppressor of Cytokine Signaling Proteins; D014255:Trichothecenes; C075944:insulin-like growth factor binding protein, acid labile subunit; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; C007262:deoxynivalenol